Heron Therapeutics Inc (HRTX)
3.20
-0.02
(-0.62%)
USD |
NASDAQ |
May 17, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Free Cash Flow: -43.40M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -43.40M |
| December 31, 2023 | -60.33M |
| September 30, 2023 | -100.49M |
| June 30, 2023 | -127.63M |
| March 31, 2023 | -128.88M |
| December 31, 2022 | -148.74M |
| September 30, 2022 | -156.44M |
| June 30, 2022 | -174.02M |
| March 31, 2022 | -208.64M |
| December 31, 2021 | -206.38M |
| September 30, 2021 | -215.78M |
| June 30, 2021 | -203.76M |
| March 31, 2021 | -198.48M |
| December 31, 2020 | -191.63M |
| September 30, 2020 | -167.46M |
| June 30, 2020 | -149.20M |
| March 31, 2020 | -116.45M |
| December 31, 2019 | -131.73M |
| September 30, 2019 | -137.82M |
| June 30, 2019 | -152.73M |
| March 31, 2019 | -189.52M |
| December 31, 2018 | -200.98M |
| September 30, 2018 | -212.30M |
| June 30, 2018 | -213.50M |
| March 31, 2018 | -183.95M |
| Date | Value |
|---|---|
| December 31, 2017 | -172.85M |
| September 30, 2017 | -163.78M |
| June 30, 2017 | -159.90M |
| March 31, 2017 | -155.57M |
| December 31, 2016 | -137.23M |
| September 30, 2016 | -121.48M |
| June 30, 2016 | -104.96M |
| March 31, 2016 | -92.80M |
| December 31, 2015 | -79.61M |
| September 30, 2015 | -70.04M |
| June 30, 2015 | -69.22M |
| March 31, 2015 | -65.95M |
| December 31, 2014 | -61.72M |
| September 30, 2014 | -57.64M |
| June 30, 2014 | -51.65M |
| March 31, 2014 | -49.82M |
| December 31, 2013 | -42.45M |
| September 30, 2013 | -39.20M |
| June 30, 2013 | -28.76M |
| March 31, 2013 | -21.85M |
| December 31, 2012 | -17.98M |
| September 30, 2012 | -14.29M |
| June 30, 2012 | -14.19M |
| March 31, 2012 | -11.74M |
| December 31, 2011 | -8.234M |
Free Cash Flow Range, Past 5 Years
-215.78M
Minimum
Sep 2021
-43.40M
Maximum
Mar 2024
-151.00M
Average
-150.96M
Median
Free Cash Flow Benchmarks
| United Therapeutics Corp | 752.40M |
| Ligand Pharmaceuticals Inc | -19.62M |
| Esperion Therapeutics Inc | -27.38M |
| Aldeyra Therapeutics Inc | -30.86M |
| Ionis Pharmaceuticals Inc | -345.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.516M |
| Cash from Investing (Quarterly) | 1.278M |
| Cash from Financing (Quarterly) | 0.011M |
| Free Cash Flow Per Share (Quarterly) | -0.0629 |
| Free Cash Flow to Equity (Quarterly) | -9.752M |
| Free Cash Flow Yield | -9.57% |